UBS Group AG - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$32,833
-16.4%
27,135
+0.2%
0.00%
Q2 2023$39,253
-34.8%
27,071
-34.8%
0.00%
Q1 2023$60,209
-23.8%
41,523
-9.1%
0.00%
Q4 2022$79,031
+71.8%
45,682
+99.4%
0.00%
Q3 2022$46,000
+4500.0%
22,908
+2934.2%
0.00%
Q2 2022$1,000
-85.7%
7550.0%0.00%
Q1 2022$7,000
-98.7%
755
-97.7%
0.00%
Q4 2021$529,000
-0.2%
33,082
+14.8%
0.00%
Q3 2021$530,000
+1863.0%
28,822
+1422.6%
0.00%
Q2 2021$27,000
-94.1%
1,893
-93.9%
0.00%
Q1 2021$456,000
+64.0%
31,027
+116.3%
0.00%
Q4 2020$278,000
+4533.3%
14,347
+2769.4%
0.00%
Q3 2020$6,000
-92.5%
500
-91.6%
0.00%
Q2 2020$80,000
+9.6%
5,952
-33.8%
0.00%
Q1 2020$73,000
-46.7%
8,993
-37.0%
0.00%
Q4 2019$137,000
+17.1%
14,267
+29.1%
0.00%
Q3 2019$117,000
-14.0%
11,051
-6.4%
0.00%
Q2 2019$136,000
+580.0%
11,802
+268.8%
0.00%
Q4 2018$20,000
-20.0%
3,200
+35.7%
0.00%
Q3 2018$25,000
+92.3%
2,359
+149.6%
0.00%
Q2 2018$13,000
+85.7%
945
+90.5%
0.00%
Q1 2018$7,000
+600.0%
496
+287.5%
0.00%
Q4 2017$1,0001280.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders